Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2025 GlobeNewswire August 07, 2025 New York, NY, Aug. 07, 2025 (GLOBE NEWSWIRE) — Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company“), a special purpose acquisition company, announced today that on August 5, 2025, […]

Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 Patient Enrollment Advances in Global Phase 3 Program for Treatment of HCV Four Scientific Posters Presented at EASL, Including Final Results from Phase 2 Study of Bemnifosbuvir/Ruzasvir Regimen Confirming 98% Sustained Virologic Response at 12 Weeks Post-Treatment (SVR12) After

Kura Oncology Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 – FDA Priority Review of New Drug Application (NDA) for ziftomenib in adults with R/R NPM1-m AML with Prescription Drug User Fee Act (PDUFA) target action date set for November 30, 2025 – – Fully engaged in commercial readiness activities in alignment with

Inuvo Posts 25% Growth in the Second Quarter 2025 Management to host conference call at 4:15 PM ET, Thursday, August 7, 2025 GlobeNewswire August 07, 2025 LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced its financial results for the

Nuvini Launches NuviniAI Lab to Accelerate AI Adoption Across Portfolio Companies and Drive Scalable Growth GlobeNewswire August 07, 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), Latin America's leading serial acquirer of B2B SaaS companies, today announced the official launch of NuviniAI Lab, a dedicated

Regeneron Announces Investor Conference Presentations GlobeNewswire August 07, 2025 TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Cantor Global Healthcare Conference 2025 at 1:35 p.m. ET on Wednesday, September 3, 2025 2025 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Thursday, September 4,

Resolute Holdings Reports Second Quarter 2025 Results GlobeNewswire August 07, 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Resolute Holdings Management, Inc. (“Resolute Holdings”) (Nasdaq: RHLD), an operating management company responsible for providing management services to CompoSecure Holdings, L.L.C. (“CompoSecure Holdings”), a wholly owned subsidiary of CompoSecure, Inc. (“CompoSecure”) (Nasdaq: CMPO), today reported financial

Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development GlobeNewswire August 07, 2025 BOTHELL, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) — Athira Pharma, Inc.

Alector Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 On track to report topline data by mid-Q4 2025 from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN, a severe, rare form of dementia with no approved treatments Ongoing Phase 2 PROGRESS-AD trial of AL101 in early

Nutanix Announces Date and Conference Call Information for Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results GlobeNewswire August 07, 2025 SAN JOSE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the fiscal fourth quarter and